* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Single Nucleotide Polymorphism (SNP) 分析與應用
Vectors in gene therapy wikipedia , lookup
History of RNA biology wikipedia , lookup
Designer baby wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
Genomic library wikipedia , lookup
Behavioural genetics wikipedia , lookup
Pathogenomics wikipedia , lookup
Genome (book) wikipedia , lookup
Point mutation wikipedia , lookup
Genome evolution wikipedia , lookup
Whole genome sequencing wikipedia , lookup
Non-coding DNA wikipedia , lookup
Deoxyribozyme wikipedia , lookup
Microevolution wikipedia , lookup
Metagenomics wikipedia , lookup
Genealogical DNA test wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
History of genetic engineering wikipedia , lookup
Human genome wikipedia , lookup
Bisulfite sequencing wikipedia , lookup
Public health genomics wikipedia , lookup
Human genetic variation wikipedia , lookup
Nucleic acid analogue wikipedia , lookup
Molecular Inversion Probe wikipedia , lookup
Single Nucleotide Polymorphism (單一核苷酸多型性) Single Nucleotide Polymorphism (SNP) 分析與應用 林照雄 國立陽明大學 生命科學系暨基因體科學研究所 生物醫學資訊研究所 生物藥學資訊研究所 Nature (2001) 409:923-933. 2 Central dogma of life Single Nucleotide Polymorphism (單一核苷酸多型性) • Human Genome Project produces numerous sequence data, and it has become evident that there is substantial variation in DNA sequences between two individuals at many points throughout the genome – genome variation. • Most commonly, sequence variation occurs at discrete, single‐nucleotide positions referred to as single nucleotide polymorphisms (SNPs), which are estimated to occur at a frequency of approximately one per 1000 nucleotides. • SNPs are biallelic polymorphisms, that is, the nucleotide identity at these polymorphic positions is generally constrained to one of two possibilities in humans, humans rather than the four nucleotide possibilities that could occur, occur in principle. For a variation to be considered a SNP, it must occur in at least 1% of the population. • SNPs have great potential for use in genetic‐mapping studies, which locate and characterize genes that are important in human disease and g ffunction. biological ‐ Biomedical researches link something to disease risks & response to therapy The Lancet (2000) 356:1749-1756. 3 Trends in Biotechnology (2000) 18:77-83. http://www.ornl.gov/sci/techresources/Human_Genome/faq/snps.shtml - SNP Fact Sheet 4 Adjacent SNPs that are inherited together are compiled into ʺhaplotypesʺ Single Nucleotide Polymorphism (單一核苷酸多型性) • SNPs are useful for finding genes that contribute to disease, in two ways. Some SNP alleles are the actual DNA sequence variants that cause differences in gene function or regulation that directly contribute to disease processes. Most SNP alleles, however, probably contribute little to disease. They are useful as genetic markers that can be used to find the functional SNPs because of associations between the marker SNPs and the functional SNPs. • SNPs of various types can change the function or the regulation and expression of a protein. The most obvious type is a nonsynonymous SNP, where the alleles differ in the amino acid of the protein product. Some polymorphisms y p at splice p sites,, and result in variant p proteins that SNPs are p differ in the exons they contain. Some SNPs are in promoter regions and are reported to affect the regulation and expression of proteins. When SNPs are associated with other SNPs, SNPs then many SNPs, SNPs in exons, exons introns, introns and other noncoding regions, may all be associated with a disease or phenotype, even though only one or a few may directly affect the phenotype phenotype. Methods in Molecular Biology (2003) page 1, vol 212 - Single Nucleotide Polymorphisms, Humana Press http://snp.cshl.org/ 5 International HapMap Project 6 Single Nucleotide Polymorphism (單一核苷酸多型性) • SNPs and other less common sequence variants are the ultimate basis for genetic differences among individuals, and thus the basis for most genetic contributions to disease. disease To make good use of SNPs for finding genes related to disease and studying their function, better and cheaper technological methods are needed for discovering SNPs, for genotyping them in many individuals, individuals for finding their frequencies in pooled samples, samples and for discerning haplotypes. New statistical methods are needed to analyze linkage and association in large‐scale studies, to relate h l haplotypes and d the h diploid d l d genotypes they h form f to disease d risk, k and d to elucidate the interactions among genes and between genes and the environment. • For SNPs to realize their full potential in genetic analysis, thousands of different SNP loci must be screened in a rapid, accurate and cost‐ p y is a p promising g tool ffor effective manner. MALDI–TOF mass spectrometry the high‐throughput screening of SNPs, with future prospects for use in genetic analysis. http://snp.cshl.org/ Methods in Molecular Biology (2003) page 1, vol 212 - Single Nucleotide Polymorphisms, Humana Press 7 8 Identification of SNP Identification of SNP Genotyping SNPs With Molecular Beacons Single‐strand conformation polymorphism (SSCP) + separation method Methods in Molecular Biology (2003) page 37, vol 212 - Single Nucleotide Polymorphisms, Humana Press Methods in Molecular Biology (2003) page 111, vol 212 - Single Nucleotide Polymorphisms, Humana Press 9 Identification of SNP 10 MALDI‐TOF mass spectrometry Strategies for SNP genotyping by primer extension using microarrays Matrix‐Assisted Laser Desorption/Ionization – Time Of Flight mass analysis linear type MH+ reflectron ionization Nature Reviews Genetics (2001) 2, 930-942. 11 Mass spectrometry is a powerful analytical technique with detection sensitivity at for a compound of mass 1000 Daltons) and accuracy at 0.01% or 5 ppm. 10‐12g (10‐15 moles 12 MALDI‐TOF mass spectrometry MALDI‐TOF mass spectrometry Matrix Mass spectrum 3-Hydroxypicolinic y yp acid (HPA) ( ) Cyano 4 hydroxy ‐Cyano‐4‐hydroxy‐ cinnamic acid (CHCA) Peptides<10kDa Sinapinic Acid (SA) Proteins >10kDa N t lC b h d t 2,5‐Dihydroxybenzoic acid 2 5 Dih d b i id Neutral Carbohydrates, Synthetic Polymers (DHB) Super DHB ( + 10% 5‐ methoxysalicylic acid ) Proteins, Glycosylated proteins 3‐Hydroxypicolinic acid (HPA) Oligonucleotides 2‐(4‐hydroxy‐phenylazo) benzoic acid (HABA) Proteins, Oligosaccharides Mol. Cell. Proteomics (2003) 422:117-126. 13 14 Advantages using MALDI‐TOF MS for nucleic acid analysis SNP analysis using MALDI‐TOF MS • Mass spectrometry is fast; ionization, separation by size, and detection of nucleic acids takes milliseconds to complete. Because signals from multiple laser pulses (~20–100 pulses) are usually averaged to obtain a final mass spectrum, the total analysis time can take as little as ten seconds. seconds • By contrast, conventional electrophoretic methods for separating and detecting nucleic acids can take hours to complete. • The results of mass spectrometry p y are absolute,, beingg based on the intrinsic property of the mass‐to‐charge ratio (m/z). This is inherently more accurate than electrophoresis‐based or hybridizationarray‐based methods, which are both susceptible to complications from secondary‐structure formation in nucleic acids. • Furthermore, h the h absolute b l nature off detection, d i combined bi d with i h the h detection d i off predominantly singly charged molecular ions, makes the analysis of complex mixtures by MALDI–TOF MS possible. • The complete automation of all steps, steps from sample preparation through to the acquisition and processing of the data, is feasible, giving MALDI–TOF MS great potential for high‐throughput nucleic acid analysis applications. DNA sequencing for SNP genotyping A: 135 Da G: 151 Da C: 111 Da PCR reactions with ddNTP for sequencing previously unknown single‐nucleotide i l k i l l id substitution mutations Non‐extended primer ‐ There is a loss of signal intensity and mass resolution with increasing DNA size; this has proven to be the major current limitation to DNA sequencing by MALDI TOF MS limitation to DNA sequencing by MALDI–TOF MS T: 126 Da Trends in Biotechnology (2000) 18:77-83. Nature Biotechnology (1998) 16:381-384. 15 16 SNP analysis using MALDI‐TOF MS SNP analysis using MALDI‐TOF MS Minisequencing Minisequencing for multiplex genotyping Mass‐tagging ddNTPs Genome Research (1997) 7:378-388. Nature Biotechnology (1998) 16:1347-1351. 17 18 SNP analysis using MALDI‐TOF MS SNP analysis using MALDI‐TOF MS MassEXTEND assay A nucleotide depletion primer extension assay homozygous A heterozygous GA No dGTP Journal of Proteome Research (2004) 3:218-227. homozygous Rapid Communication in Mass Spectrometry (2004) 18:2249-2254. 19 20 SNP analysis using MALDI‐TOF MS SNP analysis using MALDI‐TOF MS Peptide nucleic‐acid (PNA) hybridization ( ) probes • The neutral backbone increased thermal stability of the resulting duplex Detection of SNPs in double‐stranded DNA by using exonuclease III/nuclease / S1/PNA system • • • • PNA has the ability to hybridize under low ionic strength conditions PNA has an increased hybridization specificity for complementary DNA sequences PNA has an increased hybridization specificity for complementary DNA sequences PNA oligomers are useful as allele‐specific hybridization probes PNA is easily analyzed by MALDI‐TOF MS Nature Biotechnology (1997) 15:1368-1372. Nucleic Acid Research (2004) 32:e42. 21 22 SNP analysis using MALDI‐TOF MS SNP analysis using MALDI‐TOF MS SNP genotyping using invader assay and MALDI‐TOF MS SNP genotyping using RNA Indel: insertion/deletion Indel: insertion/deletion Human ApoE nt 5208‐5244 PNAS (1999) 96:6301-6306. Journal of American Society of Mass Spectrometry (2006) 17:3-8. 23 24 SNP analysis using MALDI‐TOF MS SNP analysis using MALDI‐TOF MS SNP genotyping using RNA SNP genotyping using RNA 1 2 3 4 5 RNAdel RNAdel RNAc RNAc RNAA RNAA RNAcc RNAccc 3+5 3+4 1+2 3+4+5 2+3+5 3+4+2 1+2+3+5 3+4+2+5 RNAcc RNAccc Journal of American Society of Mass Spectrometry (2006) 17:3-8. Journal of American Society of Mass Spectrometry (2006) 17:3-8. 25 Application – Hepatitis C Virus Genotyping 26 Application – Hepatitis C Virus Genotyping Determination off the h hepatitis h C virus (HCV) ( ) genotype has h become b accepted d as the h standard procedure in laboratory practice. Genotype assignment helps in disease prognosis and assists in establishing the appropriate duration of treatment. HC1a HC21 HC1b HC21 HC2a HC21 HC3a 5’ UTR HC2 HC4 HC2 HC5 HC1a HC21 HC1b HC1a HC1b HC2a HC3a HC4 HC5 HC1 HC2a HC1 HC3a HC1 HC4 HC1 HC5 HC1 HC1 HC1 HC1 HC1 HC1 HC1 HC1a HC1b HC2a HC3a HC4 HC5 HC21 HC21 HC21 HC2 HC2 HC21 HC1 Journal of Clinical Microbiology (2005) 43:2810-2815. Journal of Clinical Microbiology (2005) 43:2810-2815. 27 28 Application – Hepatitis C Virus Genotyping nonextended Application – Hepatitis C Virus Genotyping H1a H1b Journal of Clinical Microbiology (2005) 43:2810-2815. H2a Journal of Clinical Microbiology (2005) 43:2810-2815. 29 Application – Hepatitis C Virus Genotyping 30 Application – Hepatitis C Virus Genotyping HCV typing results for 69 HCV‐positive sera obtained by the minisequencing reaction y p y, p p , q g followed by mass spectrometry, allele‐specific amplification, and direct sequencing H3a H4 Journal of Clinical Microbiology (2005) 43:2810-2815. Journal of Clinical Microbiology (2005) 43:2810-2815. 31 32 Application – association of SNP with diseases Application – association of haplotype with diseases Pharmacogenomics (2003) 3:17‐26. (2003) 3:17‐26 J Mol Med (2001) 79:732‐737. Cancer Research (2002) 62:4992‐4995. h( ) PNAS (2005) 97:10483‐10488. Nature Genetics (2003) 35:349‐10488. Journal of Clinical Microbiology (2005) 43:2810-2815. 33 34